Evidence map›Paper›PMID 38971750›Full record

GuidelineBMC nephrology2024

Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024.

Sagen Zac-Varghese, Patrick Mark, Steve Bain, Debasish Banerjee, Tahseen A Chowdhury, Indranil Dasgupta, Parijat De, Damian Fogarty, Andrew Frankel, Gabrielle Goldet and 9 more

Abstract readPractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in BMC nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Novel Insights into Diabetic Kidney Disease.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sagen Zac-VargheseEast and North Herts NHS Trust, Hertfordshire, UK. sagen.zac-varghese@nhs.net.
Patrick MarkUniversity of Glasgow, Glasgow, UK.
Steve BainSwansea University, Swansea, UK.
Debasish BanerjeeGeorge's Hospital, London, UK.
Tahseen A ChowdhuryRoyal London Hospital, London, UK.
Indranil DasguptaHeartlands Hospital, Birmingham, UK.
Parijat DeBirmingham City Hospital, Birmingham, UK.
Damian FogartyBelfast Health and Social Care Trust, Belfast, Northern Ireland.
Andrew FrankelImperial College London, London, UK.
Gabrielle GoldetImperial College London, London, UK.
Janaka KarallieddeGuy's and St Thomas NHS Foundation Trust, London, UK.
Ritwika MallikUniversity College Hospital, London, UK.
Rosa MonteroGeorge's Hospital, London, UK.
Adnan SharifUniversity of Birmingham, Birmingham, UK.
Mona WahbaHelier Hospital, Carshalton, UK.
Ketan DhatariyaNorwich University Hospital, Norfolkand, UK.
Kieran McCaffertyBarts Health NHS Trust, London, UK.
Eirini LioudakiKings College London, London, UK.
Peter WinocourEast and North Herts NHS Trust, Hertfordshire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.

Indexed as

Diabetic NephropathiesAdultCardiovascular DiseasesDiabetes Mellitus, Type 2HumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsUnited KingdomHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsChronic kidney diseaseDiabetesDiabetic kidney diseaseLipid managementLipidsNephropathy

Identifiers

PMID38971750
PMCPMC11227212

What Socratic holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.